Education
About Us
Working with TipRanks
Follow Us
Intelligent Bio Solutions (INBS)
NASDAQ:INBS
RESEARCH TOOLSreports
Total Valuation
Intelligent Bio Solutions has a market cap or net worth of $9.26M. The enterprise value is $3.26M.
Market Cap$9.26M
Enterprise Value$3.26M
Share Statistics
Intelligent Bio Solutions has 6,811,578 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,811,578
Owned by Insiders3.08%
Owned by Institutions0.15%
Financial Efficiency
Intelligent Bio Solutions’s return on equity (ROE) is -1.22 and return on invested capital (ROIC) is -109.48%.
Return on Equity (ROE)-1.22
Return on Assets (ROA)-0.74
Return on Invested Capital (ROIC)-109.48%
Return on Capital Employed (ROCE)-1.23
Revenue Per Employee62.24K
Profits Per Employee-203.82K
Employee Count50
Asset Turnover0.23
Inventory Turnover2.17
Valuation Ratios
The current PE Ratio of Intelligent Bio Solutions is -0.57. Intelligent Bio Solutions’s PEG ratio is 0.01.
PE Ratio-0.57
PS Ratio0.00
PB Ratio0.70
Price to Fair Value0.70
Price to FCF-0.60
Price to Operating Cash Flow-0.61
PEG Ratio0.01
Income Statement
In the last 12 months, Intelligent Bio Solutions had revenue of 3.11M and earned -10.16M in profits. Earnings per share was -6.38.
Revenue3.11M
Gross Profit1.43M
Operating Income-10.28M
Pretax Income-10.19M
Net Income-10.16M
EBITDA-8.81M
Earnings Per Share (EPS)-6.38
Cash Flow
In the last 12 months, operating cash flow was -10.12M and capital expenditures -167.31K, giving a free cash flow of -7.82M billion.
Operating Cash Flow-10.12M
Free Cash Flow-7.82M
Free Cash Flow per Share-1.15
Dividends & Yields
Intelligent Bio Solutions pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.29
52-Week Price Change-48.39%
50-Day Moving Average1.68
200-Day Moving Average1.59
Relative Strength Index (RSI)41.11
Average Volume (3m)98.25K
Important Dates
Intelligent Bio Solutions upcoming earnings date is May 7, 2025, TBA Not Confirmed.
Last Earnings DateFeb 18, 2025
Next Earnings DateMay 7, 2025
Ex-Dividend Date―
Financial Position
Intelligent Bio Solutions as a current ratio of 1.57, with Debt / Equity ratio of 14.34%
Current Ratio1.57
Quick Ratio1.42
Debt to Market Cap0.14
Net Debt to EBITDA0.62
Interest Coverage Ratio-61.52
Taxes
In the past 12 months, Intelligent Bio Solutions has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Intelligent Bio Solutions EV to EBITDA ratio is -0.05, with an EV/FCF ratio of -0.04.
EV to Sales0.13
EV to EBITDA-0.05
EV to Free Cash Flow-0.04
EV to Operating Cash Flow-0.04
Balance Sheet
Intelligent Bio Solutions has $2.24M in cash and marketable securities with $626.01K in debt, giving a net cash position of -$1.62M billion.
Cash & Marketable Securities$2.24M
Total Debt$626.01K
Net Cash-$1.62M
Net Cash Per Share-$0.24
Tangible Book Value Per Share$1.20
Margins
Gross margin is 41.07%, with operating margin of -330.46%, and net profit margin of -326.40%.
Gross Margin41.07%
Operating Margin-330.46%
Pretax Margin-327.50%
Net Profit Margin-326.40%
EBITDA Margin-283.14%
EBIT Margin-322.12%
Analyst Forecast
The average price target for Intelligent Bio Solutions is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast23.21%
EPS Growth Forecast57.43%